Spectrum Planning & Advisory Services’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.53M | Sell |
|
|||||
|
2025
Q2 | $1.1M | Hold |
|
|||||
|
2025
Q1 | $907K | Hold |
|
|||||
|
2024
Q4 | $790K | Hold |
|
|||||
|
2024
Q3 | $924K | Sell |
|
|||||
|
2024
Q2 | $879K | Buy |
|
|||||
|
2023
Q4 | $681K | Hold |
|
|||||
|
2023
Q3 | $630K | Sell |
|
|||||
|
2023
Q2 | $681K | Hold |
|
|||||
|
2023
Q1 | $719K | Hold |
|
|||||
|
2022
Q4 | $853K | Sell |
|
|||||
|
2022
Q3 | $728K | Hold |
|
|||||
|
2022
Q2 | $530K | Hold |
|
|||||
|
2022
Q1 | $594K | Hold |
|
|||||
|
2021
Q4 | $616K | Hold |
|
|||||
|
2021
Q3 | $686K | Hold |
|
|||||
|
2021
Q2 | $616K | Hold |
|
|||||
|
2021
Q1 | $513K | Hold |
|
|||||
|
2020
Q4 | $472K | Buy |
|